JPMorgan Downgrades G1 Therapeutics (GTHX) to Underweight; 'Cautious On Cosela'
Tweet Send to a Friend
(Updated - October 6, 2023 6:26 AM EDT)
JPMorgan analyst Anupam Rama downgraded G1 Therapeutics (NASDAQ: GTHX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Anupam Rama downgraded G1 Therapeutics (NASDAQ: GTHX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
